skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
Von Hippel-Lindau Peptide Vaccine (Code C2492)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Von Hippel-Lindau Peptide Vaccine

Definition: A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein. (NCI04)

Label: Von Hippel-Lindau Peptide Vaccine

NCI Thesaurus Code: C2492 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0796336  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
VHL peptide vaccine
VHL Peptides
Von Hippel-Lindau Peptide Vaccine

External Source Codes: 
NSC Code 900100 (see NCI DTP info)
PDQ Closed Trial Search ID 43154
PDQ Open Trial Search ID 43154 (check for NCI PDQ open clinical trial info)
UMLS CUI C0796336

Other Properties:
     Name Value (qualifiers indented underneath)
code C2492
Legacy_Concept_Name Von_Hippel-Lindau_Peptide_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom